Literature DB >> 25246423

Comparing histological activity indexes in UC.

Aude Bressenot1, Julia Salleron2, Claire Bastien3, Silvio Danese4, Camille Boulagnon-Rombi5, Laurent Peyrin-Biroulet6.   

Abstract

BACKGROUND: Assessment of disease activity in UC is important for designing an optimal therapeutic strategy. No single histology score is considered optimum. The aim of this study was to compare intraobserver reproducibility and the interobserver agreement of available histological UC activity indexes.
METHODS: One hundred and two biopsy specimens (collected between 2003 and 2014) were scored blindly by three pathologists by determining Geboes, Riley, Gramlich and Gupta indexes and global visual evaluation (GVE). Intraobserver reproducibility and interobserver agreements for index and items of index were studied by intraclass correlation coefficient for quantitative parameter and by κ values and Krippendorff index for qualitative parameters. Relationship between indexes was studied by computation of Pearson's and Spearman's correlation coefficients.
RESULTS: Geboes, Riley, Gramlich and Gupta indexes and GVE showed good intraobserver reproducibility and a good interobserver agreement. Histological items that showed the best interobserver agreement were 'erosion/ulceration or surface epithelial integrity' and 'acute inflammatory cells infiltrate/neutrophils in lamina propria'. The five scores were strongly correlated.
CONCLUSIONS: Correlation between indexes is strong. Intraobserver reproducibility and interobserver agreement for all indexes is very good. Histological items that showed the best interobserver agreement are 'erosion/ulceration' and 'acute inflammatory cells infiltrate/neutrophils in lamina propria'. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Keywords:  ULCERATIVE COLITIS

Mesh:

Year:  2014        PMID: 25246423     DOI: 10.1136/gutjnl-2014-307477

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  37 in total

1.  Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

Authors:  Marcello Cintolo; Giuseppe Costantino; Socrate Pallio; Walter Fries
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 2.  Current best practice for disease activity assessment in IBD.

Authors:  Alissa J Walsh; Robert V Bryant; Simon P L Travis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-01       Impact factor: 46.802

3.  Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.

Authors:  Vanessa Mitsialis; Sarah Wall; Peng Liu; Jose Ordovas-Montanes; Tamar Parmet; Marko Vukovic; Dennis Spencer; Michael Field; Collin McCourt; Jessica Toothaker; Athos Bousvaros; Alex K Shalek; Leslie Kean; Bruce Horwitz; Jeffrey Goldsmith; George Tseng; Scott B Snapper; Liza Konnikova
Journal:  Gastroenterology       Date:  2020-05-16       Impact factor: 22.682

Review 4.  The Dual Role of Neutrophils in HIV Infection.

Authors:  Tiffany Hensley-McBain; Nichole R Klatt
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

5.  Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.

Authors:  Caroline Prieux-Klotz; Stéphane Nahon; Aurelien Amiot; Leila Sinayoko; Carole Galéano-Cassaz; Stanislas Chaussade; Romain Coriat; Pierre Lahmek; Vered Abitbol
Journal:  Dig Dis Sci       Date:  2016-11-16       Impact factor: 3.199

6.  Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.

Authors:  Wing Yan Mak; Anthony Buisson; Michael J Andersen; Donald Lei; Joel Pekow; Russell D Cohen; Stacy A Kahn; Bruno Pereira; David T Rubin
Journal:  Dig Dis Sci       Date:  2018-02-22       Impact factor: 3.199

Review 7.  Histologic scoring indices for evaluation of disease activity in ulcerative colitis.

Authors:  Mahmoud H Mosli; Claire E Parker; Sigrid A Nelson; Kenneth A Baker; John K MacDonald; G Y Zou; Brian G Feagan; Reena Khanna; Barrett G Levesque; Vipul Jairath
Journal:  Cochrane Database Syst Rev       Date:  2017-05-25

8.  Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Protect against Colitis by Regulating Gut Innate and Adaptive Immune Responses.

Authors:  Jennifer Lee; Pedro M Moraes-Vieira; Angela Castoldi; Pratik Aryal; Eric U Yee; Christopher Vickers; Oren Parnas; Cynthia J Donaldson; Alan Saghatelian; Barbara B Kahn
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

9.  Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study.

Authors:  Talia Zenlea; Eric U Yee; Laura Rosenberg; Marie Boyle; Kavinderjit S Nanda; Jacqueline L Wolf; Kenneth R Falchuk; Adam S Cheifetz; Jeffrey D Goldsmith; Alan C Moss
Journal:  Am J Gastroenterol       Date:  2016-03-15       Impact factor: 10.864

10.  Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1).

Authors:  Klaus Fellermann; Ingolf Schiefke; István Rácz; Jelena Derova; Laimas Jonaitis; Sarah Wehrum; Tanju Nacak; Roland Greinwald
Journal:  United European Gastroenterol J       Date:  2020-10-07       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.